Who Owns Chemed Company?

Chemed Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

Who Owns Chemed Corporation?

Understanding Chemed Corporation's ownership is key to grasping its strategic path and governance. Established in 1970 in Delaware, it began as a subsidiary of W.R. Grace and Company before going public in 1971.

Who Owns Chemed Company?

Chemed operates two major segments: VITAS Healthcare, a leading hospice provider, and Roto-Rooter, a prominent plumbing and water cleanup service. As of August 2025, Chemed boasts a market cap of C$9.20 billion and TTM revenue of $2.51 billion USD.

Who owns Chemed Corporation?

Institutional investors are the primary owners of Chemed Corporation. As of August 2025, these entities collectively hold a significant majority of the company's shares. Vanguard Group, Inc. is a major shareholder, followed by BlackRock, Inc. and State Street Corporation. These institutions manage vast portfolios and their investment decisions significantly influence Chemed's market performance and strategic direction. For a deeper look into the external factors affecting the company, consider a Chemed PESTEL Analysis.

Who Founded Chemed?

The ownership structure of Chemed Company at its inception was unique, diverging from typical startup models. Incorporated in Delaware in 1970 and becoming publicly traded in 1971, Chemed originated as a subsidiary of W.R. Grace and Company. This corporate lineage means Chemed wasn't founded by individual entrepreneurs with initial equity stakes.

Aspect Details
Incorporation Year 1970
Public Trading Year 1971
Origin Subsidiary of W.R. Grace and Company
Founding Structure Corporate spin-off, not individual founders
Initial Backer W.R. Grace and Company
Icon

Corporate Origins

Chemed Corporation's early days were marked by its formation as a subsidiary, indicating a strategic move by its parent company rather than a grassroots startup. This corporate background shaped its initial ownership.

Icon

Public Offering

The company transitioned to public trading in 1971, facilitated by its parent organization. This step was crucial in establishing its independent market presence and ownership distribution.

Icon

Absence of Individual Founders

Public records do not detail specific individual founders or their equity percentages at Chemed's inception. Its establishment was a corporate event, not a venture initiated by personal entrepreneurship.

Icon

Parent Company's Role

W.R. Grace and Company served as the primary early backer, instrumental in Chemed's initial public offering. This relationship defined the early ownership landscape.

Icon

Transition to Independence

Chemed's early ownership was characterized by its evolution from a subsidiary to a publicly listed entity. This transition was driven by the parent company's strategic objectives for its diversified services business.

Icon

No Founder Agreements

Standard startup agreements like vesting schedules or buy-sell clauses were not applicable to Chemed's foundational period due to its corporate origin. Ownership was not tied to individual founder contributions in the typical sense.

The early ownership of Chemed Company was intrinsically linked to its parent, W.R. Grace and Company, which facilitated its incorporation and subsequent public offering. This corporate structure meant that traditional founder-centric ownership models, complete with individual equity splits and vesting schedules, did not apply. Instead, the initial ownership was a reflection of the parent company's strategic decision to spin off this diversified services business, marking a transition from subsidiary status to an independently traded entity. Understanding Mission, Vision & Core Values of Chemed provides context for the strategic direction set during its early corporate evolution.

Icon

Key Ownership Factors

Chemed's early ownership was shaped by its corporate origins and public market debut.

  • Origin as a subsidiary of W.R. Grace and Company.
  • Publicly traded since 1971.
  • Initial ownership driven by corporate strategy, not individual founders.
  • W.R. Grace and Company was the primary early backer.

Chemed SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

How Has Chemed’s Ownership Changed Over Time?

Since its 1971 IPO, the ownership of the Chemed Company has seen a significant transformation, with institutional investors becoming the dominant stakeholders. This shift reflects growing confidence in the company's long-term prospects and financial performance.

Shareholder Type Percentage of Ownership (Approx.) Key Entities
Institutional Investors 95.85% (August 2025) Vanguard Group Inc., BlackRock, Inc., Kayne Anderson Rudnick Investment Management Llc, iShares Core S&P Mid-Cap ETF (IJH), Neuberger Berman Group LLC, State Street Corp, Morgan Stanley
Insiders (Executives & Board Members) 1.16% (February 2025) Mr. Kevin J. McNamara (President & CEO)

The ownership structure of the Chemed Company is heavily weighted towards institutional investors, indicating a strong reliance on these entities for capital and strategic direction. As of August 2025, these large investment funds collectively owned approximately 95.85% of the company's stock. This high level of institutional ownership suggests that the company's governance and strategic decisions are likely influenced by the investment philosophies and performance expectations of these major shareholders. Understanding the Revenue Streams & Business Model of Chemed can provide further insight into why these institutions maintain significant stakes.

Icon

Chemed Company's Ownership Landscape

The Chemed Company's ownership is predominantly held by institutional investors, with a smaller percentage owned by company insiders.

  • Institutional investors held approximately 95.85% of Chemed stock by August 2025.
  • Key institutional shareholders include Vanguard Group and BlackRock.
  • Insiders, such as the CEO, held around 1.16% as of February 2025.
  • This ownership concentration implies significant influence from large investment funds on company strategy.

Chemed PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

Who Sits on Chemed’s Board?

The Board of Directors for Chemed Corporation is instrumental in the company's governance, with nine directors elected at the 2025 annual stockholders' meeting. This board structure connects directly to the company's ownership, guiding its strategic direction and oversight. Key figures include President & CEO Kevin J. McNamara, who has been a director since 1987, alongside Lead Independent Director Henry E. Daly, Jr., and committee chairs David P. Williams and A. George Battle.

Director Name Role Director Since
Kevin J. McNamara President & Chief Executive Officer 1987
Henry E. Daly, Jr. Lead Independent Director
David P. Williams Chair of the Audit Committee
A. George Battle Chair of the Nominating and Governance Committee

Chemed Corporation operates under a standard one-share-one-vote system, meaning each share of capital stock typically carries one vote. This structure is evident in the director election process and the approval of executive compensation and stock incentive plans. While specific details regarding dual-class shares or special voting rights are not prominently disclosed, the company's governance appears to follow conventional practices. Insider holdings, though representing a minor portion of the total shares, include significant stakes by key executives. For instance, as of February 2025, Kevin J. McNamara held 0.65% of the company's stock, and Thomas C. Hutton held 0.21%, both exerting direct voting influence. There have been no recent public reports of proxy battles or activist campaigns that have substantially altered Chemed's established governance framework, indicating a stable ownership and control environment. Understanding the Marketing Strategy of Chemed can provide further context on how ownership influences business decisions.

Icon

Understanding Chemed's Voting Power

Chemed Corporation's voting power is primarily distributed through its standard one-share-one-vote structure. This system ensures that ownership directly translates into influence over corporate decisions.

  • All outstanding shares of capital stock generally carry equal voting rights.
  • Director elections are a key area where voting power is exercised by shareholders.
  • Executive compensation and stock plans also require shareholder approval, reflecting voting influence.
  • Insider holdings, though small, grant key executives direct voting power.

Chemed Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

What Recent Changes Have Shaped Chemed’s Ownership Landscape?

Over the past few years, Chemed Corporation has demonstrated a consistent strategy of returning value to shareholders and expanding its operations, particularly within its hospice segment. These actions have influenced its ownership trends, with institutional investors maintaining a significant presence.

Development Date Details
Stock Repurchase Authorization August 2025 Additional $300 million authorized, following a $300 million authorization in November 2024.
Quarterly Share Repurchases Quarter ending June 30, 2025 75,000 shares repurchased for $42.9 million.
Dividend Increase August 2025 Quarterly cash dividend raised from $0.50 to $0.60 per share (20.0% increase).
Leadership Transition Effective December 1, 2025 Nicholas M. Westfall departs; Joel L. Wherley to succeed him as CEO of VITAS Healthcare.
Acquisition by VITAS Healthcare April 2024 Substantially all hospice operations and an assisted living facility acquired from Covenant Health and Community Services, Inc. for $85 million.

Institutional investors remain the dominant force in Chemed's ownership structure, holding approximately 95.85% of the company's stock as of August 2025. This high level of institutional ownership reflects confidence in Chemed's business model, which combines stable, recession-resistant services in distinct industries. The company's management anticipates improvements in both its businesses during the latter half of 2025, with ongoing initiatives to address Medicare cap issues and expand VITAS's presence in new Florida locations.

Icon Shareholder Value Initiatives

Chemed has continued its commitment to shareholder returns through substantial stock repurchase programs. The company also increased its quarterly cash dividend, signaling financial strength and confidence in future performance.

Icon Strategic Expansion in Healthcare

The acquisition by VITAS Healthcare of hospice operations and an assisted living facility for $85 million in April 2024 underscores Chemed's focus on strengthening its position in the healthcare sector, particularly in hospice care.

Icon Dominance of Institutional Ownership

As of August 2025, institutional investors held a commanding 95.85% of Chemed's stock. This indicates a strong reliance on institutional backing for the company's valuation and strategic direction.

Icon Leadership and Operational Outlook

A notable leadership transition is set for December 1, 2025, with a new CEO for VITAS Healthcare. The company anticipates operational improvements in the second half of 2025, supported by strategic initiatives. Understanding the Target Market of Chemed is crucial to appreciating these developments.

Chemed Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.